grapesharvester schreef op 10 maart 2016 00:14:
Gilead Sciences Inc. (GILD): Chairman and CEO John C Martin sold 100,000 shares
Martin sold 100,000 shares on March 1 at an average price of $88.58. Gilead Sciences has a market cap of $122.31 billion; its shares were traded at around $89.44 with a P/E ratio of 7.51 and P/S ratio of 4.21. The dividend yield of Gilead Sciences stocks is 1.43%. Gilead Sciences had an annual average earnings growth of 45.90% over the past five years.
Gilead Sciences Inc. declared its 2015 full year results. The company reported total net sales of $32.6 billion and net income of $18.1 billion.
Chairman and CEO John C Martin sold 600,000 shares of GILD stock from November to March. EVP and CFO Robin L Washington sold 12,500 shares of GILD stock in November and February. EVP Commercial Ops Paul Rutherford Carter, President, COO and Director John F Milligan, and Director Gayle E Wilson together sold 124,650 shares of GILD stock in January, February, and March.
------
Waarom/waarvoor die verkopen? Mogen zij privé bijvoorbeeld Galapagos aandelen kopen?